Patent Assignment
Reel/Frame 060487/0601
Assignment of Assignor's Interest
Recorded: 2022-07-12
Pages: 20
Assignor
OSIRIS THERAPEUTICS, INC.
Executed: 2013-10-10
Assignee
MESOBLAST INTERNATIONAL SÁRL
ROUTE DE PRE-BOIS 20, MEYRIN, 1217, SWITZERLAND
Covered Property
(1)
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application:
16/694,382 →
Publication:
US 2020/0197444
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Assignment of Assignor's Interest
Jul 12, 2022
From: DANILKOVITCH, ALLA; NEWMAN, ROBERT E., JR.; TOM, SAMSON; TON, CHRISTOPHER
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 060487/0522 →
Release of Security Interest in Intellectual Property
Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →